ID

42651

Descripción

De-intensification of Radiation and Chemotherapy for Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01530997 The purpose of this research study is to learn about the effectiveness of using lower-intensity radiation and chemotherapy to treat human papillomavirus (HPV) associated low-risk oropharyngeal and/or unknown primary squamous cell carcinomas of the head and neck. The cure rate for this type of cancer is estimated to be high, > 90%. The standard treatment for this cancer is 7 weeks of radiation with 3 high doses of cisplatin. Sometimes surgery is performed afterwards. This standard regimen causes a lot of side effects and long term complications. This study is evaluating whether a lower dose of radiation and chemotherapy may provide a similar cure rate as the longer, more intensive standard regimen. Patients in this study will receive 1 less week of radiation and a lower weekly dose of chemotherapy followed by a limited surgical evaluation.

Link

https://clinicaltrials.gov/show/NCT01530997

Palabras clave

  1. 29/6/19 29/6/19 -
  2. 17/9/21 17/9/21 -
Titular de derechos de autor

UNC Lineberger Comprehensive Cancer Center

Subido en

17 de septiembre de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :


Sin comentarios

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Radiation in Low-Risk HPV Squamous Cell Carcinoma NCT01530997

Eligibility Criteria

  1. StudyEvent: Eligibility
    1. Eligibility Criteria
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
Is the participant above 18 years of age?
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
Does the participant have t0-3, n0 to n2c, m0 squamous cell carcinoma of the oropharynx?
Descripción

Oropharyngeal squamous cell carcinoma stage

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0280313
UMLS CUI [1,2]
C1515169
UMLS CUI [2]
C0445081
UMLS CUI [3]
C0475371
UMLS CUI [4]
C0475373
UMLS CUI [5]
C0475374
UMLS CUI [6]
C0445034
Does the participant have. biopsy proven squamous cell carcinoma that is HPV and/or p16 positive?
Descripción

HPV/p16 positive squamous cell carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0280313
UMLS CUI [1,2]
C0005558
UMLS CUI [1,3]
C4288937
UMLS CUI [2,1]
C0280313
UMLS CUI [2,2]
C0005558
UMLS CUI [2,3]
C4289892
Does the participant have ≤ 10 pack-years smoking history or > 5 years of abstinence from smoking?
Descripción

Smoking history

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C4721824
UMLS CUI [1,2]
C1277691
UMLS CUI [2]
C0814442
Did the participant have history/physical examination within 8 weeks prior to registration?
Descripción

History/physical examination

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C2985881
UMLS CUI [2,1]
C0031809
UMLS CUI [2,2]
C0332152
UMLS CUI [2,3]
C2985881
Does the participant have radiologic confirmation of the absence of hematogenous metastasis within 12 weeks prior to registration?
Descripción

No metastasis seen

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0043299
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C1512376
UMLS CUI [1,4]
C0027627
UMLS CUI [1,5]
C0332152
UMLS CUI [1,6]
C2985881
Does the participant have an ecog performance status 0-1?
Descripción

ECOG

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
Does the participant have a CBC/Differential obtained within 4 weeks prior to registration, with adequate bone marrow function defined as follows: absolute neutrophil count (anc) ≥ 1,800 cells/mm3; platelets ≥ 100,000 cells/mm3; hemoglobin ≥ 8.0 g/dl?
Descripción

Adequate bone marrow function

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009555
UMLS CUI [1,2]
C0205411
UMLS CUI [1,3]
C0005953
UMLS CUI [1,4]
C0542341
UMLS CUI [2,1]
C0545131
UMLS CUI [2,2]
C0205411
UMLS CUI [2,3]
C0005953
UMLS CUI [2,4]
C0542341
UMLS CUI [3]
C0948762
UMLS CUI [4]
C0032181
UMLS CUI [5]
C0518015
Does the participant have adequate renal and hepatic function within 4 weeks prior to registration, defined as follows: serum creatinine < 2.0 mg/dl; total bilirubin < 2 x the institutional uln; ast or alt < 3 x the institutional uln?
Descripción

Adequate Renal and Hepatic function

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0205411
UMLS CUI [1,2]
C0232741
UMLS CUI [2,1]
C0205411
UMLS CUI [2,2]
C0232804
UMLS CUI [3]
C0201976
UMLS CUI [4]
C0201913
UMLS CUI [5]
C0004002
UMLS CUI [6]
C0001899
Does the participant have a negative serum pregnancy test within 2 weeks prior to registration for women of childbearing potential?
Descripción

Negative serum pregnancy test

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0430061
UMLS CUI [1,2]
C3831118
Does the participant practice adequate contraception during treatment and for 6 weeks following treatment, if they are a women of childbearing potential or male participants who are sexually active?
Descripción

Adequate contraception

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0205411
UMLS CUI [1,2]
C0700589
UMLS CUI [1,3]
C0332282
UMLS CUI [1,4]
C0087111
UMLS CUI [1,5]
C4324275
UMLS CUI [2,1]
C0205411
UMLS CUI [2,2]
C0700589
UMLS CUI [2,3]
C0332282
UMLS CUI [2,4]
C0087111
UMLS CUI [2,5]
C0241028
UMLS CUI [2,6]
C0025266
Is the participant deemed able to comply with the treatment plan and follow-up schedule?
Descripción

Able to comply

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0582784
UMLS CUI [2,1]
C0085732
UMLS CUI [2,2]
C0725694
UMLS CUI [2,3]
C1522577
Does the participant provide study specific informed consent prior to study entry?
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
Does the participant have a prior history of radiation therapy to the head and neck?
Descripción

History of head/neck radiation

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0018670
UMLS CUI [1,3]
C0027530
Does the participant have a prior history of head and neck cancer?
Descripción

Head/Neck cancer

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0278996
Does the participant have a severe, active co-morbidity, defined as follows: unstable angina and/or congestive heart failure requiring hospitalization within the last 6 months; transmural myocardial infarction within the last 6 months; acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration; chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy at the time of registration; hepatic insufficiency resulting in clinical jaundice and/or coagulation defects; note, however, coagulation parameters are not required for entry into this protocol; pre-existing ≥ grade 2 neuropathy; prior organ transplant?
Descripción

Severe active comorbidity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0205082
UMLS CUI [1,2]
C0205177
UMLS CUI [1,3]
C0009488
UMLS CUI [1,4]
C1704788
UMLS CUI [2,1]
C0002965
UMLS CUI [2,2]
C0019993
UMLS CUI [3,1]
C0018802
UMLS CUI [3,2]
C0019993
UMLS CUI [4]
C1400513
UMLS CUI [5,1]
C0004623
UMLS CUI [5,2]
C0013125
UMLS CUI [5,3]
C0003232
UMLS CUI [6,1]
C0026946
UMLS CUI [6,2]
C0013125
UMLS CUI [6,3]
C0003235
UMLS CUI [7,1]
C0740304
UMLS CUI [7,2]
C0019993
UMLS CUI [8]
C1306571
UMLS CUI [9]
C0442874
UMLS CUI [10]
C0524930
Is the participant known HIV positive?
Descripción

HIV positive

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019699
Does the participant have significant pre-existing hearing loss, as defined by the patient or treating physician?
Descripción

Significant hearing loss

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2347662
UMLS CUI [1,2]
C3887873
UMLS CUI [1,3]
C0030705
UMLS CUI [1,4]
C0011900
UMLS CUI [2,1]
C2347662
UMLS CUI [2,2]
C3887873
UMLS CUI [2,3]
C0030705
UMLS CUI [2,4]
C0031831

Similar models

Eligibility Criteria

  1. StudyEvent: Eligibility
    1. Eligibility Criteria
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
Is the participant above 18 years of age?
boolean
C0001779 (UMLS CUI [1])
Oropharyngeal squamous cell carcinoma stage
Item
Does the participant have t0-3, n0 to n2c, m0 squamous cell carcinoma of the oropharynx?
boolean
C0280313 (UMLS CUI [1,1])
C1515169 (UMLS CUI [1,2])
C0445081 (UMLS CUI [2])
C0475371 (UMLS CUI [3])
C0475373 (UMLS CUI [4])
C0475374 (UMLS CUI [5])
C0445034 (UMLS CUI [6])
HPV/p16 positive squamous cell carcinoma
Item
Does the participant have. biopsy proven squamous cell carcinoma that is HPV and/or p16 positive?
boolean
C0280313 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
C4288937 (UMLS CUI [1,3])
C0280313 (UMLS CUI [2,1])
C0005558 (UMLS CUI [2,2])
C4289892 (UMLS CUI [2,3])
Smoking history
Item
Does the participant have ≤ 10 pack-years smoking history or > 5 years of abstinence from smoking?
boolean
C4721824 (UMLS CUI [1,1])
C1277691 (UMLS CUI [1,2])
C0814442 (UMLS CUI [2])
History/physical examination
Item
Did the participant have history/physical examination within 8 weeks prior to registration?
boolean
C0262926 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C2985881 (UMLS CUI [1,3])
C0031809 (UMLS CUI [2,1])
C0332152 (UMLS CUI [2,2])
C2985881 (UMLS CUI [2,3])
No metastasis seen
Item
Does the participant have radiologic confirmation of the absence of hematogenous metastasis within 12 weeks prior to registration?
boolean
C0043299 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C1512376 (UMLS CUI [1,3])
C0027627 (UMLS CUI [1,4])
C0332152 (UMLS CUI [1,5])
C2985881 (UMLS CUI [1,6])
ECOG
Item
Does the participant have an ecog performance status 0-1?
boolean
C1520224 (UMLS CUI [1])
Adequate bone marrow function
Item
Does the participant have a CBC/Differential obtained within 4 weeks prior to registration, with adequate bone marrow function defined as follows: absolute neutrophil count (anc) ≥ 1,800 cells/mm3; platelets ≥ 100,000 cells/mm3; hemoglobin ≥ 8.0 g/dl?
boolean
C0009555 (UMLS CUI [1,1])
C0205411 (UMLS CUI [1,2])
C0005953 (UMLS CUI [1,3])
C0542341 (UMLS CUI [1,4])
C0545131 (UMLS CUI [2,1])
C0205411 (UMLS CUI [2,2])
C0005953 (UMLS CUI [2,3])
C0542341 (UMLS CUI [2,4])
C0948762 (UMLS CUI [3])
C0032181 (UMLS CUI [4])
C0518015 (UMLS CUI [5])
Adequate Renal and Hepatic function
Item
Does the participant have adequate renal and hepatic function within 4 weeks prior to registration, defined as follows: serum creatinine < 2.0 mg/dl; total bilirubin < 2 x the institutional uln; ast or alt < 3 x the institutional uln?
boolean
C0205411 (UMLS CUI [1,1])
C0232741 (UMLS CUI [1,2])
C0205411 (UMLS CUI [2,1])
C0232804 (UMLS CUI [2,2])
C0201976 (UMLS CUI [3])
C0201913 (UMLS CUI [4])
C0004002 (UMLS CUI [5])
C0001899 (UMLS CUI [6])
Negative serum pregnancy test
Item
Does the participant have a negative serum pregnancy test within 2 weeks prior to registration for women of childbearing potential?
boolean
C0430061 (UMLS CUI [1,1])
C3831118 (UMLS CUI [1,2])
Adequate contraception
Item
Does the participant practice adequate contraception during treatment and for 6 weeks following treatment, if they are a women of childbearing potential or male participants who are sexually active?
boolean
C0205411 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0332282 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])
C4324275 (UMLS CUI [1,5])
C0205411 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C0332282 (UMLS CUI [2,3])
C0087111 (UMLS CUI [2,4])
C0241028 (UMLS CUI [2,5])
C0025266 (UMLS CUI [2,6])
Able to comply
Item
Is the participant deemed able to comply with the treatment plan and follow-up schedule?
boolean
C0582784 (UMLS CUI [1])
C0085732 (UMLS CUI [2,1])
C0725694 (UMLS CUI [2,2])
C1522577 (UMLS CUI [2,3])
Informed Consent
Item
Does the participant provide study specific informed consent prior to study entry?
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
History of head/neck radiation
Item
Does the participant have a prior history of radiation therapy to the head and neck?
boolean
C1522449 (UMLS CUI [1,1])
C0018670 (UMLS CUI [1,2])
C0027530 (UMLS CUI [1,3])
Head/Neck cancer
Item
Does the participant have a prior history of head and neck cancer?
boolean
C0278996 (UMLS CUI [1])
Severe active comorbidity
Item
Does the participant have a severe, active co-morbidity, defined as follows: unstable angina and/or congestive heart failure requiring hospitalization within the last 6 months; transmural myocardial infarction within the last 6 months; acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration; chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy at the time of registration; hepatic insufficiency resulting in clinical jaundice and/or coagulation defects; note, however, coagulation parameters are not required for entry into this protocol; pre-existing ≥ grade 2 neuropathy; prior organ transplant?
boolean
C0205082 (UMLS CUI [1,1])
C0205177 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C1704788 (UMLS CUI [1,4])
C0002965 (UMLS CUI [2,1])
C0019993 (UMLS CUI [2,2])
C0018802 (UMLS CUI [3,1])
C0019993 (UMLS CUI [3,2])
C1400513 (UMLS CUI [4])
C0004623 (UMLS CUI [5,1])
C0013125 (UMLS CUI [5,2])
C0003232 (UMLS CUI [5,3])
C0026946 (UMLS CUI [6,1])
C0013125 (UMLS CUI [6,2])
C0003235 (UMLS CUI [6,3])
C0740304 (UMLS CUI [7,1])
C0019993 (UMLS CUI [7,2])
C1306571 (UMLS CUI [8])
C0442874 (UMLS CUI [9])
C0524930 (UMLS CUI [10])
HIV positive
Item
Is the participant known HIV positive?
boolean
C0019699 (UMLS CUI [1])
Significant hearing loss
Item
Does the participant have significant pre-existing hearing loss, as defined by the patient or treating physician?
boolean
C2347662 (UMLS CUI [1,1])
C3887873 (UMLS CUI [1,2])
C0030705 (UMLS CUI [1,3])
C0011900 (UMLS CUI [1,4])
C2347662 (UMLS CUI [2,1])
C3887873 (UMLS CUI [2,2])
C0030705 (UMLS CUI [2,3])
C0031831 (UMLS CUI [2,4])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial